Table 3. Characteristics of the Patients According to the Presence of Bleeding Complications.
| Bleeding |
P | ||
|---|---|---|---|
| Present (n = 32) |
Absent (n = 64) |
||
| n (%) | n (%) | ||
| Age, year | |||
| < 65 | 11 (34.4) | 31 (48.4) | 0.190 |
| ≥ 65 | 21 (65.6) | 33 (51.6) | |
| Sex | |||
| Male | 18 (56.2) | 28 (43.8) | 0.248 |
| Female | 14 (43.8) | 36 (56.2) | |
| Reasons for warfarin therapy | |||
| Atrial fibrillation | 18 (56.3) | 39 (60.9) | 0.659 |
| Stroke | 6 (18.8) | 10 (15.6) | 0.699 |
| Cardiac valve prosthesis | 3 (9.4) | 6 (9.4) | 1.000 |
| Antithrombin III deficiency | 3 (9.4) | 2 (3.1) | - |
| Pulmonary embolism | 2 (6.3) | 3 (4.7) | - |
| Peripheral artery disease | 1 (3.1) | 3 (4.7) | - |
| Deep vein thrombosis | 1 (3.1) | 1 (1.6) | - |
| Duration of warfarin use | |||
| ≤ 1 year | 5 (15.6) | 7 (10.9) | 0.527 |
| > 1 year | 27 (84.4) | 57 (89.1) | |